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Aim: To describe the prevalence of hypertension in care home residents, its treatment, change in
treatment over time, and the achievement of blood pressure (BP) control.
Method: The PubMed, Cochrane, Embase, and PsychINFO databases were searched for observational
studies involving care home residents with a diagnosis of hypertension. The search was limited to
English language articles involving adults and humans published from 1990 onward. Abstracts and titles
were reviewed with eligible articles read in full. Bibliographies were examined for further relevant
studies. The ﬁnal selection of studies was then analyzed and appraised.
Results: Sixteen articles were identiﬁed for analysis, of which half were studies carried out in the United
States. The prevalence of hypertension in care home residents was 35% (range 16%e71%); 72% of these
were on at least 1 antihypertensive (mean 1.5 antihypertensives per individual), with diuretics being the
most common. The prevalence of hypertension in study populations was greater in more recent studies
(P ¼ .004). ACEi/ARBs (P ¼ .001) and b-blockers (P ¼ .04) were prescribed more frequently in recent
studies, whereas use of calcium-channel blockers and diuretics remained unchanged over time. The
number of antihypertensives prescribed per patient was higher (correlation 0.332, P ¼ .009), whereas
fewer patients achieved target BP (correlation 0.671, P ¼ .099) in more recent studies.
Conclusion: Hypertension is common in care home residents and is commonly treated with antihyper-
tensive drugs, which were prescribed more frequently in more recent studies but with no better BP
control. These studies indicate a tendency toward increasing polypharmacy over time, with associated
risk of adverse events, without demonstrable beneﬁt in terms of BP control.
Copyright  2014 - American Medical Directors Association, Inc.Hypertension is common in older people, approximately 80% of
those older than 80 are hypertensive,1 and even at these ages,
hypertension remains a risk factor for cardiovascular and cerebro-
vascular disease. A number of trials of antihypertensive medication,
including the Hypertension in the Very Elderly Trial (HYVET),2 the
Systolic Hypertension in Europe Study (Syst-Eur),3 the Systolic
Hypertension in the Elderly Program (SHEP),4 and the Study on
Cognition and Prognosis in the Elderly (SCOPE),5 demonstrated that
antihypertensives can bring beneﬁts in the oldest old. However, the
average trial patient bears little resemblance to the many very old
people who live in care homes, who are often cognitively and
physically impaired because of multiple comorbidities, who are
exposed to multiple medications,6 and where chronic diseaseSc, Division of Rehabilitation
iversity of Nottingham, B99, B
. Welsh).
merican Medical Directors Associamanagement is often suboptimal.7 Although terminology describing
long term care facilities varies from country to country,8 in the
United Kingdom, the term “care home” describes institutions that
provide “accommodation, together with nursing or personal care, for
persons who are or have been ill, who have or have had a mental
disorder, who are disabled or inﬁrm, or are or have been dependent
on alcohol or drugs.”9 They include homes with and without 24-hour
on-site nursing staff, known as residential and nursing homes,
respectively.
Given the marked vulnerability of care home residents, there is
concern that they may not beneﬁt from aggressive management of
blood pressure in the same way that study populations do.
Conversely, there are also concerns that care home residents may be
undertreated for long-term conditions compared with their
community-dwelling peers. To inform rational service and research
responses to hypertension for patients resident in this sector, we set
out to describe the prevalence of hypertension in care home resi-
dents, whether and how it is treated and how treatment patterns
have changed over time.tion, Inc.
T. Welsh et al. / JAMDA 15 (2014) 8e16 9Method
A prespeciﬁed protocol was used to search for and identify suit-
able articles.
Eligibility
Study characteristics
Observational studies conducted in care homes describing the
prevalence of hypertension and treatments used.
Report characteristics
NoneEnglish-language articles and studies carried out before
1990 were excluded.
Information Sources
A systematic search of the literature was conducted by searching
electronic databases, and scanning reference lists of articles. The
following databases were used: PubMed (1946 e present), Cochrane,
Embase (1974 e present), and PsychINFO (1806 e present). The last
full search was run on November 14, 2012, with updates to this until
April 2013.
Search
The following search terms were used and were adapted for each
database as appropriate: care home, nursing home, residential home,
care homes, nursing homes, residential homes, care-home, nursing-
home, residential-home, residential facilities, homes for the aged, long
term care facility, long-term care facility, long-term care, hyperten-
sion, blood pressure, antihypertensive, management, treatment.
An example search strategy is provided in Appendix 1.
The search was then limited to English-language articles, to
studies involving humans, and to studies involving adults.
Study Selection
The title and abstract of the retrieved records were assessed
against the eligibility criteria by one reviewer (T.W.) in a standardized
manner. Where there was uncertainty about eligibility, the full article
was reviewed. The bibliographies of eligible articles were searched
for further relevant articles, which were again appraised against
eligibility criteria.
Data Collection and Items
Relevant data were extracted from the articles and entered into
a structured database that recorded (1) characteristics of the trial
patients, (2) type of trial and country, (3) prevalence of hypertension,
(4) antihypertensive agents used, and (5) achievement of target blood
pressure.
Assessment of Risk of Bias
The risk of bias was assessed using the tool developed by Agency
for Healthcare Research and Quality (AHRQ)10 (Appendix 2). This al-
lowed systematic review of different potential sources of bias for each
study type. The risk of bias for each study is summarized in Table 1.
Method of Synthesis
Having extracted the data from the selected articles, the combined
data were analyzed to test whether there had been any change
in treatment patterns over time using regression analysis. Wherenecessary, data from the articles were transformed to facilitate
comparison.
Results
A total of 6170 citations were identiﬁed initially, and after
applying limits and removing duplicates this was reduced to 2792
citations. Of these, 2765 articles were rejected after review of the
abstract demonstrated that they did not meet the eligibility criteria.
The full text of the remaining 27 articles was then reviewed in detail.
Fifteen of these articles were then discarded because of failure to
meet the eligibility criteria at more detailed review. An additional 8
articles were identiﬁed by review of the included article’s bibliogra-
phies. Four of these were found to meet the eligibility criteria. In total,
therefore, 16 articles were included in the review (Figure 1).
Characteristics of Studies
The characteristics of individual studies are summarized in
Table 2. Of the 16 articles, 8 reported studies were conducted in the
United States,11e18 2 each in Canada19,20 and the United Kingdom,7,21
and 1 each in Germany,22 France,23 Italy,24 and Malaysia.25
Methods
All 16 studieswere observational cross-sectional studies; in addition,
2 studies7,22 used a matched control group. Eight of the
studies13,14,17e19,23e25 collected prospective data, the remaining 8
retrospectively analyzed data, 2 used the results of the US National
NursingHomes Survey,15,16 2 used databases compiledwith information
from the minimum dataset used in the United States and Canada for all
nursing home admissions,12,20 the 2 UK studies used databases built
using data held by general practitioners,7,21 and the remaining 2 retro-
spectively analyzed digital and hard copy data from nursing homes.11,22
The selection method was not reported in 3 of the studies,11,19,24
and in 4 studies the nursing homes involved were afﬁliated with
the local university or medical center.13,14,18,25 Two studies used data
from the National Nursing Home Survey, a nationally representative
sample of US nursing homes.15,16
Participants
The included studies involved 102,429 people with hypertension
of a total population of 328,667. The inclusion criteria were residence
in a care home or equivalent and a diagnosis of hypertension. Fish
and colleagues11 were more speciﬁc and included only those in which
hypertension was the sole identiﬁable indication for antihypertensive
prescription.
Objectives
The objectives of the studies varied. One study aimed to identify
the cost of antihypertensive treatment.11 Two studies aimed to
compare the quality of care received by care home residents with
community-dwelling older people.7,21 One set out to compare the
adequacy of hypertension management in care homes and in the
community.22 Ten studies aimed to describe the prevalence of
hypertension and treatment patterns in care homes, and 2 of this
group12,16 also aimed to compare this with concurrent guidelines.Individual Study Findings
The ﬁndings of each individual study are summarized in Table 3.
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T. Welsh et al. / JAMDA 15 (2014) 8e1610Synthesis of Results
Data were combined from each study where available. As Si-
monson and colleagues15 and Drawz and colleagues16 used the
same data set, only the data presented by Drawz and colleagues16
were used in the synthesis, giving a total of 15 studies included.
Characteristics of Study Participants
The average age of the patients across the studies was 82, with
most (71%) being female. The population had a high burden of
comorbidity, with 32% experiencing falls, 39% dementia, 25% coro-
nary heart disease, 28% cerebrovascular disease, and 23% diabetes
mellitus.
Prevalence
The prevalence of hypertension in care home residents as re-
ported by these studies varied between a minimum of 16%24 and
a maximum of 71%.17,18,22 The mean prevalence of hypertension
across the studies was 35% (SD 18.4%). The prevalence increased
over time, when later studies and earlier studies were compared,
the lowest estimate being 16% in 199124 and the highest being 71%
in 201022 (correlation coefﬁcient: 0.682, P ¼ .004).
Prescribing Patterns
Of the 9 studies11e14,16e19,22 that reported details of treatment,
between 70% and 100% of their participants were on at least one
antihypertensive agent. Combined across all the studies, a mean of
72% were on at least one antihypertensive agent.
Overall, diuretics (27%, range 24%e66%), calcium channel
blockers (26%, range 18%e30%), and angiotensin-converting enzyme
inhibitors/angiotensin receptor blockers (ACEi/ARBs) (24.6%, range
22%e65%) were most commonly used, whereas b-blockers were less
commonly used (10.8%, range 8%e75%).
A higher proportion of the hypertensive care home population
took ACEi/ARBs (correlation coefﬁcient: 0.875, R2 ¼ 0.736, P ¼ .001)
and b-blockers (correlation coefﬁcient: 0.654, R2 ¼ 0.427, P ¼ .04) in
later studies than in earlier studies, whereas the use of calcium
channel blockers and diuretics remained static over time.
Number of Antihypertensive Agents and Target Blood Pressure
There was a signiﬁcant increase in the number of antihyper-
tensive classes prescribed, when older studies were compared with
more recent studies, from an average of 1.1 in 1994 to 2.0 in 2007
(correlation coefﬁcient: 0.770, P ¼ .025), with the median increasing
from 1 in 1994 to 2 in 2010.
When results from these studies were combined, 70% of those
with hypertension had blood pressure readings within the target
range. This compared to ﬁgures of 49% on treatment in the US
population (1994) with 22% reaching target blood pressures26 and
63% on treatment with 27% reaching target levels as recorded in the
National Health and Nutrition Examination Survey (NHANES)
database 1999e2000.27 Blood pressure control was no better in
recent studies compared with older studies, and there is a trend
toward poorer control over time (correlation coefﬁcient: e0.671,
R2 ¼ 0.450, P ¼ .099).
Discussion
The review demonstrated that hypertension is common in care
home residents and is often treated. The prevalence of hypertension
is higher in later studies than in earlier studies. The number of
Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) ﬂow diagram.
T. Welsh et al. / JAMDA 15 (2014) 8e16 11antihypertensive classes used per patient increased over time and the
classes of antihypertensives used differed in more recent studies
compared with older studies. ACE inhibitors, ARBs, and b-blockers
were prescribed more frequently in more recent studies, whereas
calcium channel blockers and diuretics have not shown any signiﬁ-
cant change in prescribing over time. Although the number of anti-
hypertensive classes used has increased, the proportion of
participants with adequate blood pressure control has not.
Studies carried out in the United States dominated the literature.
This reﬂects, to an extent, the large amount of care home literature
produced in the United States.28 There are well-recognized differ-
ences in the composition of the population resident in long term care
between countries7 and also differences in how doctors prescribed
for long-term conditions,29 which means that there are some caveats
about generalizing these ﬁndings.
Four of the articles selected for the review were located through
the bibliographies of other studies. It is possible that other studies
may have been missed by the electronic search and may not have
been found in reference lists. Articles not in English were omitted.
We are unaware of any previous systematic review looking at
the treatment of hypertension in care home residents. Similarly, we
are unaware of any speciﬁc guidance for the treatment of hyper-
tension in care home residents with which to compare these
ﬁndings. The increasing prevalence of hypertension seen over time
may relate either to increasing awareness of hypertension and
hence an increased rate of diagnosis and recording of the diagnosis,
or an increasing true prevalence of hypertension in the general
population.27 The rise over time in the use of b-blockers wasunexpected, as most guidance no longer recommends them for the
treatment of hypertension and favors the use of calcium channel
blockers. This could be an example of a treatment lag in this po-
pulation, or that other factors, such as heart failure, are acting as
confounders. However, treatment rates for hypertension in care
home populations were higher than in noncare home hypertensive
populations (70% vs 63%),27 which does not support the hypothesis
that the treatment of this long-term condition is overlooked in care
home residents.
Conclusion
Despite the use of increasing numbers of antihypertensive agents
in care home residents, there has been no improvement in the control
of their blood pressure. These vulnerable people are therefore being
exposed to an increased risk of side effects without the intended
beneﬁt. This increase in the number of agents may well reﬂect the
growing problem of polypharmacy, which has been extensively
documented and discussed over the past few years.30 These ﬁndings
justify further study of the treatment of hypertension in care homes
in countries outside the United States. They also justify reexamination
of whether the beneﬁt of treatment exceeds the harm in some
diagnostic groups resident in care homes, such as those with
dementia in whom the risk of side effects may be particularly high.
The ﬁndings also remind clinicians to take particular care to weigh
potential beneﬁts and harms in prescribing for hypertension in care
home residents, given that increasing treatment does not necessarily
lead to better blood pressure control.
Table 2
Summary of Studies’ Characteristics
Source [Reference No.] Type of Study No. of Patients No. With
Hypertension (%)
Mean Age
(Range)
Location Country Identiﬁcation of
Hypertensive Patients
Blood
Pressure
Measured
Selection Method
Manopulo and Sturani
199124
Cross-sectional 108 17 (16) 78.6 (65e90) 2 nursing homes Italy Recorded diagnosis Yes Not stated
Fish et al 199511 Cross-sectional
Retrospective review
of charts
550 (only 50
included in
the study)
150 (27) 87 (50e106) Long term care residents United States Recorded diagnosis.
(Only those with
hypertension as the
sole indication for
an antihypertensive
were included)
Yes Not stated
Gambassi et al 199812 Cross-sectional
Retrospective review
of database
270,148 80,206 (30) 82.7 (65e115) Nursing home population
of 5 states (Kansas, Maine,
Mississippi, New York,
South Dakota)
United States Recorded diagnosis No Not stated (availability of
the data set)
Trilling et al 199813 Cross-sectional 804 355 (44) Not available 3 care homes (two veterans’
homes)
United States Recorded diagnosis Yes NHs afﬁliated with the
university
Maxwell et al 200020 Cross-sectional
Retrospective review
of minimum data set
23,655 5241 (22) 80.7 (SD 7.7) Chronic hospital patients Canada Recorded diagnosis No Not stated. (availability of
the data set)
Fahey et al 20037 Controlled observational
study
Retrospective
172 34 (20) 85 (SD 7) Four nursing homes United Kingdom Recorded diagnosis No Via 3 general practitioner
practices. Random selection
of controls
Ziesmer et al 200314 Cross-sectional
Chart audit
255 129 (51) 77 (68e86) Single academic nursing
home
United States According to the criteria
of JNC VI
Yes Nursing home afﬁliated with
the medical center
Koka et al 200718 Cross-sectional 202 143 (71) 73 (50e98) Single academic nursing
home
United States According to the criteria
of JNC VII
Yes Nursing home afﬁliated with
the medical center
Coover et al 200817 Cross-sectional 966 683 (71) 78.1 (SD 17.2) Single skilled nursing facility United States Recorded diagnosis Yes 12 skilled nursing facilities
were chosen
Tsuyuki et al 200819 Cross-sectional
Chart audit
2063 733 (36) 84 (SD 8) 15 long term care facilities Canada Recorded diagnosis Yes Not stated
Drawz et al 200916 Cross-sectional 13,507 7129 (53) 81.6 Data from the NNHS 2004 United States Recorded diagnosis No NNHS
Rolland et al 200923 Cross-sectional 4920 2676 (54) 85.7 (SD 8.8) Single care home France Recorded diagnosis No Survey of Nursing homes
within a region. All i
nvited, participation
was voluntary
Ong et al 201025 Cross-sectional 205 74 (36) (62e98) Single care home Malaysia Recorded diagnosis and
measured blood pressure
Yes Author is visiting medical
ofﬁcer for the facility
Shah et al 201121 Cross-sectional
Retrospective review of
database
10387 4446 (43) 85.5 Care home United Kingdom Recorded diagnosis No Volunteer sample of UK
general practices’ data
Simonson et al 201115 Cross-sectional 13,507 7272 (54) 81.8 Data from NNHS 2004 United States Recorded diagnosis No NNHS
Lochner et al 201222 Cross-sectional
With matched controls
Retrospective
725 513 (71) 85.9 (SD 7.1) 4 nursing homes Germany Recorded diagnosis Yes Four of 23 invited homes
JNC, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; NNHS, National Nursing Home Survey.
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Table 3
Summary of the Studies’ Findings
Source Prevalence of
Hypertension
Sex Comorbidities Antihypertensive
Types
No. of Antihypertensives Mean No. of
Antihypertensives
Effectiveness (Meets
Target <140/90)
Manopulo and Sturani 199124 16% 83% F
17% M*
Falls 80% d d d Not measured
Fractures d
Incontinence d
CHD d
CCF d
CVD d
Dementia d
DM d
Fish et al 199511 27% Not stated Falls d ACEi/ARB: 22% None: N/A d Not measured
Fractures d Diuretic: 66% One: 66%
Incontinence d CC Blockers: 18% Two: 26%
CHD d b-Blockers: 18% Three: 8%
CCF d a-Blockers: 6%
CVD d Other: 12%
Dementia d
DM d
Gambassi et al 199812 32% 77% F
23% M
Falls 32% ACEi/ARB: 22% None: 30% 1.13 (SD 0.97) Not Measured
Fractures 9% Diuretic: 25% One: 38%
Incontinence 46% CC Blockers: 26% Two: 21%
CHD 26% b-Blockers: 8% Three: 11%
CCF 22% a-Blockers: 3%
CVD 29% Other: 16%
Dementia 39%
DM 23%
Trilling et al 199813 44% 26% F
74% M
Falls d ACEi/ARB: 28% None: 24% 1.16 (SD 0.88) 88.8%
Hip fracture 3.7% Diuretic: 28% One: 44%
Incontinence d CC Blockers: 30% Two: 24%
CHD 54% b-Blockers: 8% Three: 5%
CCF d a-Blockers: 5% Four or More: 1%
CVD 38% Other: d
Dementia 40%
DM 25%
Maxwell et al 200020 22% 65% F
35% M
Falls d d d d Not measured
Fractures d
Incontinence d
CHD 19%
CCF 16%
CVD 47%
Dementia 23%
DM 26%
Fahey et al 20037 51% 77% F
23% M
Falls d d d d Not measured
Fractures d
Incontinence d
CHD 13%
CCF d
CVD d
Dementia d
DM 8%
Ziesmer et al 200314 20% 62% F
38% M
Falls d ACEi/ARB: 54% None: 0 1.7 (SD 0.78) 84%
Fractures d Diuretic: 33% One: 50%
Incontinence d CC Blockers: 28% Two: 30%
CHD 45% b-Blockers: 47% Three: 18%
CCF 24% a-Blockers: 4% Four or More: 2%
CVD 31% Other: 4%
Dementia d
DM 42%
(continued on next page)
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Table 3 (continued )
Source Prevalence of
Hypertension
Sex Comorbidities Antihypertensive
Types
No. of Antihypertensives Mean No. of
Antihypertensives
Effectiveness (Meets
Target <140/90)
Koka et al 200718 71% 51% F
49% M
Falls d ACEi/ARB: 62% None: 0% 2.03 (SD 0.76) 85%
Fractures d Diuretic: 34% One: 27%
Incontinence d CC Blockers: 29% Two: 43%
CHD d b-Blockers: 75% Three: 22%
CCF d a-Blockers: 4% Four or More: 9%
CVD d Other: 10%
Dementia d
DM d
Coover et al 200817 71% 76% F
24% M*
Falls d ACEi/ARB: 64% None: 14% 1.65 (SD 0.99) 71%
Fractures d Diuretic: 56% One: 30%
Incontinence d CC Blockers: 29% Two: 33%
CHD 38%* b-Blockers: 13% Three: 17%
CCF d a-Blockers: d Four or More: 6%
CVD 14%* Other: 10%
Dementia d
DM 48%*
Tsuyuki et al 200819 38% 67% F
33% M
Falls d ACEi/ARB: 65% None: 23% 1.29 (SD 0.96) 64%
Fractures d Diuretic: 24% One: 37%
Incontinence d CC Blockers: 30% Two: 28%
CHD 33% b-Blockers: 20% Three or More: 12%
CCF d a-Blockers: d
CVD 45% Other: d
Dementia 65%
DM 27%
Drawz et al 200916 53% 73% F
27% M
Falls d ACEi/ARB: 42% None: 16% d Not measured
Fractures d Diuretic: 45% One: 33%
Incontinence d CC Blockers: 26% Two or More 52%
CHD 23% b-Blockers: 37%
CCF 21% a-Blockers: d
CVD 3% Other: 12%
Dementia d
DM 29%
Rolland et al 200923 54% 74% F
26% M*
Falls d d d d Not measured
Fractures d
Incontinence d
CHD (MI) 8.8%*
CCF d
CVD 7.1%*
Dementia 44%*
DM 8.7%*
Ong et al 201025 36% 51% F
49% M
Falls d d d d 53%
Fractures d
Incontinence d
CHD d
CCF d
CVD d
Dementia d
DM d
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T. Welsh et al. / JAMDA 15 (2014) 8e1616Appendix 1. Search Strategy Medline (PubMed)(1) care home
(2) nursing home
(3) residential home
(4) care homes
(5) nursing homes
(6) residential homes
(7) care-home
(8) nursing-home
(9) residential-home
(10) residential facilities
(11) homes for the aged
(12) long term care facility
(13) long-term care facility
(14) long-term care
(15) long term care
(16) 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12
OR 13 OR 14 OR 15
(17) hypertension
(18) blood pressure
(19) antihypertensive
(20) 17 OR 18 OR 19
(21) management
(22) treatment
(23) 21 OR 22
(24) 16 AND 20 AND 23Appendix 2. Bias Assessment Tool
Adapted from “Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions,” a guide published by the
Agency for Healthcare Research and Quality, Department of Health and Human Services.10Risk of Bias Criterion
Selection bias Did the study apply inclusion/exclusion criteria uniformly to all comparison groups?
Does the design or analysis control account for important confounding and modifying variables through matching, stratiﬁcation, multivariable
analysis, or other approaches?
Did researchers rule out any impact from a concurrent intervention or an unintended exposure that might bias results?
If attrition (overall or differential nonresponse, dropout, loss to follow-up, or exclusion of participants) was a concern, were missing data handled
appropriately (eg, intention-to-treat analysis and imputation)?
Performance bias Were the outcome assessors blinded to the intervention or exposure status of participants?
Attrition bias Were interventions/exposures assessed/deﬁned using valid and reliable measures, implemented consistently across all study participants?
Detection bias Were outcomes assessed/deﬁned using valid and reliable measures, implemented consistently across all study participants?
Were confounding variables assessed using valid and reliable measures, implemented consistently across all study participants?
Were the potential outcomes prespeciﬁed by the researchers? Are all prespeciﬁed outcomes reported?
Publication bias Suspicion of publication bias?
